Scott M. Wasserman
Private Equity Investor at Frazier Management LLC
Scott M. Wasserman active positions
Companies | Position | Start | End |
---|---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01/10/2023 | - |
Career history of Scott M. Wasserman
Former positions of Scott M. Wasserman
Companies | Position | Start | End |
---|---|---|---|
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Chief Executive Officer | 01/05/2019 | 01/06/2023 |
AMGEN INC. | Private Equity Investor | 01/06/2005 | 01/05/2019 |
Training of Scott M. Wasserman
Haverford College | Undergraduate Degree |
Harvard Medical School | Graduate Degree |
Stanford University School of Medicine | Undergraduate Degree |
Statistics
International
United States | 7 |
Operational
Private Equity Investor | 2 |
Undergraduate Degree | 2 |
Chief Executive Officer | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AMGEN INC. | Health Technology |
Private companies | 2 |
---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |
- Stock Market
- Insiders
- Scott M. Wasserman
- Experience